- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Neal Dave, PharmD, Discusses the Importance of Consistently Reevaluating the Cost-Effectiveness of Biosimilars
Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, talks about the importance of conducting regular evaluations to ensure that prescribing the most cost-effective option, whether that be a biosimilar or the reference product.
Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, talks about the importance of conducting regular evaluations to ensure that prescribing the most cost-effective option, whether that be a biosimilar or the reference product.
Transcript:
Could you explain some of the price declines that we've seen among oncology biosimilars and the significance of this?
Yeah, it's so important to measure. So, we switched our patients that were on Procrit [epoetin alfa] over to the biosimilar because of the cost savings. But it's important to realize that you do need to reevaluate where you are with which product that you're using because the prices can change. And so, just because it's a biosimilar and maybe when it was first released, it was the lowest cost product, that doesn't mean that it's going to stay that way.
Even the prices of the [reference] drugs are coming down. So, it's important to reevaluate that from time to time, whatever your cadence is, to ensure that what you're using is still actually cost-effective and that you're not actually increasing cost of care.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
